PuSH - Publikationsserver des Helmholtz Zentrums München: Diabetic neuropathy differs between type 1 and type 2 diabetes: Insights from magnetic resonance neurography.

Informationen

Hinweise zu Qualitätskriterien von Zeitschriften

Open-Access-Richtlinie der Helmholtz-Gemeinschaft 2016

CC Licencences

Metriken für Publikationen

Navigation

Startseite

English

Recherche

Erweiterte Suche

Durchblättern nach ...

... HMGU-Autoren/Konsortien

... Organisationsstruktur

... Zeitschriften

... Publikationstypen

... Forschungsdaten

... Arbeitsgruppen

... Erscheinungsjahr

Publikationen im Überblick

Statistik

HGF Fortschrittsbericht

OA Publikationen

Eintragen

Neue Publikation eintragen

Neue Publikation holen aus...

...EVA

Fehlende Publikation melden

Highlights

Suche

Hilfe & Kontakt

Ansprechpartner

Hilfe

Datenschutz

Helmholtz Open Science

Bibliometrische Indikatoren

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Jende, J.M.E.* ; Groener, J.B.* ; Oikonomou, D.* ; Heiland, S.* ; Kopf, S.* ; Pham, M.* ; Nawroth, P.P. ; Bendszus, M.* ; Kurz, F.T.*

Diabetic neuropathy differs between type 1 and type 2 diabetes: Insights from magnetic resonance neurography.

Ann. Neurol. 83, 588-598 (2018)

Verlagsversion

DOI

	Licenced for HMGU

Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.

Abstract
Metriken
Zusatzinfos

ObjectiveTo visualize and quantify differences of microstructural nerve damage in distal symmetric diabetic neuropathy (DPN) between type 1 diabetes (T1D) and type 2 diabetes (T2D), and to detect correlations between neuropathic symptoms and serological risk factors. MethodsThree-tesla magnetic resonance neurography of the sciatic nerve was performed in 120 patients (T1D, n=35; T2D, n=85) with either DPN (n=84) or no DPN (n=36). Results were subsequently correlated with clinical, serological, and electrophysiological patient data. ResultsT2-weighted (T2w)-hyperintense lesions correlated negatively with tibial compound motor action potential (r=-0.58, p<0.0001) and peroneal nerve conduction (r=0.51, p=0.0002), and positively with neuropathy disability score (NDS; r=-0.54, p<0.0001), neuropathy symptom score (NSS; r=0.52, p<0.0001), and HbA1c level (r=0.23, p=0.014). T2w-hypointense lesions correlated positively with NDS (r=0.28, p=0.002), NSS (r=0.36, p<0.0001), and serum triglycerides (r=0.34, p=0.0003), and negatively with serum high-density lipoprotein (HDL; r=-0.48, p<0.0001). For DPN in T1D, elevated values of T2w-hyperintense lesions (19.674.13% vs 12.49 +/- 1.23%, p=0.027) and HbA1c (8.74 +/- 0.29% vs 7.11 +/- 0.16%, p<0.0001) were found when compared to T2D. For DPN in T2D, elevated T2w-hypointense lesions (23.41 +/- 2.69mm(3) vs 11.43 +/- 1.74mm(3), p=0.046) and triglycerides (220.70 +/- 23.70mg/dl vs 106.60 +/- 14.51mg/dl, p<0.0001), and lower serum HDL (51.29 +/- 3.02mg/dl vs 70.79 +/- 4.65mg/dl, p<0.0001) were found when compared to T1D. InterpretationThe predominant type of nerve lesion in DPN differs between T1D and T2D. Correlations found between lesion type and serological parameters indicate that predominant nerve lesions in T1D are associated with poor glycemic control and loss of nerve conduction, whereas predominant lesions in T2D are associated with changes in lipid metabolism. These findings may be helpful for future studies on the underlying pathophysiological pathways and possible treatments for DPN in T1D and T2D. Ann Neurol 2018;83:588-598

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Scopus
Cited By

Altmetric

10.244

2.641